Jian Ming-Yuan, Liu Yanping, Li Qian, Wolkowicz Paul, Alexeyev Mikhail, Zmijewski Jaroslaw, Creighton Judy
Department of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine, Center for Lung Injury and Repair.
Division of Endocrinology, Diabetes, and Metabolism.
Am J Physiol Lung Cell Mol Physiol. 2016 Jan 1;310(1):L71-85. doi: 10.1152/ajplung.00227.2015. Epub 2015 Nov 6.
Injury to the pulmonary circulation compromises endothelial barrier function and increases lung edema. Resolution of lung damage involves restoring barrier integrity, a process requiring reestablishment of endothelial cell-cell adhesions. However, mechanisms underlying repair in lung endothelium are poorly understood. In pulmonary microvascular endothelium, AMP kinase α1 (AMPKα1) stimulation enhances recovery of the endothelial barrier after LPS-induced vascular damage. AMPKα1 colocalizes to a discrete membrane compartment with the adhesion protein neuronal cadherin (N-cadherin). This study sought to determine N-cadherin's role in the repair process. Short-hairpin RNA against full-length N-cadherin or a C-terminally truncated N-cadherin, designed to disrupt the cadherin's interactions with intracellular proteins, were expressed in lung endothelium. Disruption of N-cadherin's intracellular domain caused translocation of AMPK away from the membrane and attenuated AMPK-mediated restoration of barrier function in LPS-treated endothelium. AMPK activity measurements indicated that lower basal AMPK activity in cells expressing the truncated N-cadherin compared with controls. Moreover, the AMPK stimulator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) failed to increase AMPK activity in cells expressing the modified N-cadherin, indicating uncoupling of a functional association between AMPK and the cadherin. Isolated lung studies confirmed a physiologic role for this pathway in vivo. AMPK activation reversed LPS-induced increase in permeability, whereas N-cadherin inhibition hindered AMPK-mediated repair. Thus N-cadherin coordinates the vascular protective actions of AMPK through a functional link with the kinase. This study provides insight into intrinsic repair mechanisms in the lung and supports AMPK stimulation as a modality for treating vascular disease.
肺循环损伤会损害内皮屏障功能并加重肺水肿。肺损伤的恢复涉及恢复屏障完整性,这一过程需要重新建立内皮细胞间的黏附。然而,肺内皮修复的潜在机制尚不清楚。在肺微血管内皮中,AMP激酶α1(AMPKα1)的激活可增强脂多糖(LPS)诱导的血管损伤后内皮屏障的恢复。AMPKα1与黏附蛋白神经钙黏蛋白(N-钙黏蛋白)共定位于一个离散的膜区室。本研究旨在确定N-钙黏蛋白在修复过程中的作用。针对全长N-钙黏蛋白或C末端截短的N-钙黏蛋白设计的短发夹RNA在肺内皮中表达,旨在破坏钙黏蛋白与细胞内蛋白质的相互作用。N-钙黏蛋白细胞内结构域的破坏导致AMPK从膜上移位,并减弱了LPS处理的内皮细胞中AMPK介导的屏障功能恢复。AMPK活性测量表明,与对照相比,表达截短N-钙黏蛋白的细胞中基础AMPK活性较低。此外,AMPK刺激剂5-氨基咪唑-4-甲酰胺核糖核苷酸(AICAR)未能增加表达修饰N-钙黏蛋白的细胞中的AMPK活性,表明AMPK与钙黏蛋白之间的功能关联解偶联。离体肺研究证实了该途径在体内的生理作用。AMPK激活可逆转LPS诱导的通透性增加,而N-钙黏蛋白抑制则阻碍AMPK介导的修复。因此,N-钙黏蛋白通过与激酶的功能联系来协调AMPK的血管保护作用。本研究深入了解了肺内的内在修复机制,并支持将AMPK激活作为治疗血管疾病的一种方式。